Skip to content
Lincomycin
Lincocin (lincomycin) is a small molecule pharmaceutical. Lincomycin was first approved as Lincocin on 1982-01-01. It is used to treat pneumococcal infections and staphylococcal infections in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
infectionsD007239
Trade Name
FDA
EMA
Lincocin (generic drugs available since 2015-06-04)
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Lincomycin hydrochloride
Tradename
Company
Number
Date
Products
LINCOCINMylanN-050317 RX1982-01-01
1 products, RLD, RS
Show 1 discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
lincocinNew Drug Application2019-02-27
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
pneumococcal infectionsEFO_0000772D011008J13
staphylococcal infections—D013203A49.01
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
J: Antiinfectives for systemic use
— J01: Antibacterials for systemic use
— J01F: Macrolides, lincosamides and streptogramins
— J01FF: Lincosamides
— J01FF02: Lincomycin
HCPCS
Code
Description
J2010
Injection, lincomycin hcl, up to 300 mg
Clinical
Clinical Trials
2 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Chronic painD059350HP_0012532————11
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameLINCOMYCIN
INNlincomycin
Description
Lincomycin is a carbohydrate-containing antibiotic produced by the actinomyces Streptomyces lincolnensis. It has a role as an antimicrobial agent and a bacterial metabolite. It is a carbohydrate-containing antibiotic, a S-glycosyl compound, a monocarboxylic acid amide, a pyrrolidinecarboxamide and a L-proline derivative.
Classification
Small molecule
Drug classantibiotics (Streptomyces strain)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCC[C@@H]1C[C@@H](C(=O)N[C@H]([C@@H](C)O)[C@H]2O[C@H](SC)[C@H](O)[C@@H](O)[C@H]2O)N(C)C1
Identifiers
PDB—
CAS-ID154-21-2
RxCUI6398
ChEMBL IDCHEMBL1447
ChEBI ID6472
PubChem CID3000540
DrugBankDB01627
UNII IDBOD072YW0F (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 7,645 documents
View more details
Safety
Black-box Warning
Black-box warning for: Lincocin
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
339 adverse events reported
View more details